Artificial Intelligence in Medical Sciences: Innovations in Precision Medicine and Biotechnology

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 54

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

AIMS02_242

تاریخ نمایه سازی: 29 تیر 1404

چکیده مقاله:

Background and Aims: Artificial intelligence (AI) is rapidly transforming the field of medical sciences, with significant impacts on precision medicine and biotechnology. This review aims to comprehensively analyze AI's applications in genomic analysis, diagnostic imaging, and pharmaceutical development, highlighting its potential to enhance diagnostic accuracy, treatment efficiency, and personalized care. Methods: A systematic review of recent literature, tools, and methodologies was conducted to examine how AI, including machine learning and deep learning, is integrated into various domains of medical science. The review focuses on up-to-date advances in genomic data analysis, diagnostic imaging, and drug discovery, ensuring a thorough synthesis of current knowledge and innovations. Results: AI significantly improves genomic analysis by enabling the rapid identification of genetic variations and disease susceptibility, facilitating personalized treatment plans. In diagnostics, AI-powered imaging and molecular data analysis reduce human error and enable early disease detection through improved radiological and histopathological assessments. Additionally, AI expedites drug discovery in pharmaceutical development by predicting drug-target interactions and optimizing clinical trials. Notable examples include the use of AI platforms like BenevolentAI for drug repurposing and DeepMind’s AlphaFold for protein structure prediction, which have accelerated the development of targeted therapies. Conclusion: AI is a transformative tool in medical sciences, contributing to improved patient outcomes, treatment personalization, and innovation in biotechnology. However, data privacy, ethical considerations, and regulatory barriers must be addressed to ensure AI's responsible and effective integration into precision medicine. Future efforts should focus on overcoming these challenges to fully realize AI's potential in advancing medical science.

کلیدواژه ها:

نویسندگان

Hosein Samadieh

Department of Biotechnology, Faculty of Agriculture, Isfahan University of Technology, Isfahan ۸۴۱۵۶-۸۳۱۱۱, Iran.

Majid Talebi

Department of Biotechnology, Faculty of Agriculture, Isfahan University of Technology, Isfahan ۸۴۱۵۶-۸۳۱۱۱, Iran.

Badreddin Ebrahim Sayed Tabatabaei

Department of Biotechnology, Faculty of Agriculture, Isfahan University of Technology, Isfahan ۸۴۱۵۶-۸۳۱۱۱, Iran.

Mahin Samadieh

Department of Food Science and Technology, Faculty of Agriculture, Isfahan University of Technology, Isfahan, ۸۳۱۱۱-۸۴۱۵۶, Iran